Blog: Pharmacy News & Industry Information - Page 26

Your go-to blog for updates in the world of pharmacy. Find pharmacy news, career tips, hiring trends and much more.

Patients with Relapsing MS May Find Help from Plegridy Injections

The FDA has recently announced the approval of a new drug used to treat relapsing multiple sclerosis. Manufacturer Biogen Idec Inc. announced their peg interferon beta-1a injection, known as Plegridy, received approval as a treatment option for relapsing forms of MS. By attaching a polyethylene glycol molecule to the interferon beta-1a, it extends the medication’s […]

October is Healthy Lung Month

While most people know October as National Breast Cancer Awareness Month, few also know it is Healthy Lung Month. As a pharmacist, you can help your patients learn more about how to keep their lungs healthy and strong, providing extra education throughout October.

Helping the Community: Pharmacists & Psychiatric Provider Status

Recently, the Missouri Department of Mental Health approved pharmacists to step into the role of psychiatric care provider. The decision has created a more efficient community treatment team. Since community psychiatry involves reaching out to people wherever you find them (at home, in restaurants, even under bridges) to provide care and support, it is difficult […]

RPh on the Go Wins for Youth

Steve Sidell is the Director of Quality Assurance and Compliance at RPh on the Go. He began his career as a pharmacist prior to joining RPh on the Go 15 years ago. He is an avid biker, with about 37 years of fitness, sport, and transportation cycling under his belt. A little over a week […]

September: National Preparedness Month

If there was an emergency in your local area right now, would you be ready? The Centers for Disease Control and Prevention (CDC) want you to focus on being ready for anything at anytime – and that’s what September is all about. 2014 is the 11th year for the National Preparedness Month – sponsored by […]

FDA Approves Topical Antifungal for Toenails

In June, Valeant Pharmaceuticals International Inc. announced FDA approval for their medication Jublia, or efinaconazole. The topical solution is approved for the treatment of toenail onychomycosis as a result of either Trichophyton rubrum or Trichophyton mentagrophytes.